Benzinga | Feb 25, 2021 08:46AM EST

Akebia Therapeutics Q4 EPS $(0.60) Misses $(0.40) Estimate, Sales $56.70M Beat $51.16M Estimate

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.40) by 50 percent. This is a 24.05 percent increase over losses of $(0.79) per share from the same period last year. The company reported quarterly sales of $56.70 million which beat the analyst consensus estimate of $51.16 million by 10.83 percent. This is a 18.48 percent decrease over sales of $69.56 million the same period last year.